SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-106651
Filing Date
2017-03-31
Accepted
2017-03-31 16:32:03
Documents
2
Period of Report
2017-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d353827d8k.htm 8-K 15275
2 EX-99.1 d353827dex991.htm EX-99.1 10792
  Complete submission text file 0001193125-17-106651.txt   27128
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17730811
SIC: 2836 Biological Products, (No Diagnostic Substances)